The expanding evidence base for rTMS treatment of depression.


PURPOSE OF REVIEW Daily left prefrontal transcranial magnetic stimulation (TMS) for several weeks was first proposed as an acute treatment for depression in the early 1990s, and was Food and Drug Administration (FDA) approved in 2008. In the past year, several important studies have been published that extend our understanding of this novel treatment… (More)
DOI: 10.1097/YCO.0b013e32835ab46d